Location History:
- Amsterdam, NL (2018)
- Amstelveen, NL (2009 - 2024)
Company Filing History:
4 out of 4 
1 out of 1 
1 out of 11 Years Active: 2009-2025
Title: The Innovative Contributions of Petrus Josephus Ferdinandus Snijders
Introduction
Petrus Josephus Ferdinandus Snijders is a prominent inventor based in Amstelveen, Netherlands, noted for his contributions to medical technology through his innovative patents. With a total of six patents, Snijders has made significant strides in the detection and classification of cancers, particularly those associated with the human papillomavirus (HPV). His work has the potential to greatly enhance diagnostic techniques in the field of oncology.
Latest Patents
One of Snijders' latest innovations is a methylation classifier for the detection of HPV-induced high-grade precancerous lesions, invasive cancers, and non-HPV-induced gynecological and anogenital cancers. This invention includes a method for detecting a methylation classifier that consists of the genes LHX8, ASCL1, and ST6GALNAC5 along with their regulatory sequences. The detection method identifies hypermethylation, which serves as an indicator for the presence of HPV-induced precursor lesions with invasive potential and other malignancies. Additionally, the invention encompasses the use of this methylation classifier and a test kit designed for the detection of LHX8, ASCL1, and/or ST6GALNAC5 methylation.
Career Highlights
Snijders has collaborated with notable companies such as Self-screen B.V. and Stichting Researchfonds Pathologie, where his expertise in molecular diagnostics has been pivotal. His innovative approach and research have positioned him at the forefront of cancer detection methods, contributing to early diagnosis and treatment strategies.
Collaborations
In his career, Snijders has worked alongside dedicated professionals, including Christophorus Joannes Lambertus Maria Meijer and Renske Daniëla Maria Steenbergen. These collaborations underscore the importance of teamwork and shared expertise in driving forward innovative solutions in healthcare.
Conclusion
Petrus Josephus Ferdinandus Snijders has established himself as a significant figure in the field of medical innovation, particularly in cancer detection technologies. With his ongoing work and six patents to his name, he exemplifies the impact that dedicated inventors can have on improving medical diagnostics and patient outcomes. As research in this field continues to evolve, Snijders' contributions will likely play a crucial role in shaping future healthcare solutions.